GRPN has clawed back 2.7% on Tuesday to close at $16.61 — a modest stabilisation after last week's brutal 11.6% decline — yet the short base and borrow market are telling a story of remarkable entrenchment rather than capitulation.
The short side has barely budged. SI eased a further 2.3% on the week to 30.9% of the free float, continuing the slow grinding-lower trend flagged in previous notes. But the trajectory here is glacial. A month ago, SI ran at roughly 34% of float. It has taken four weeks of stock weakness — the price has shed more than 20% from its $20-plus highs — to bring that figure down by just three percentage points. Shorts are trimming at the edges, not retreating in any meaningful way. The borrow market confirms that picture: availability runs at just 1.7%, up from the 0.5% floor hit on June 5 but still deep in near-fully-locked territory. For every hundred shares already on loan, fewer than two remain available to borrow. The lending pool has been at or near full capacity for the better part of six weeks running. Cost to borrow, at 1.68%, is flat on the week and has shown almost no volatility across the past month — no sign of a squeeze premium building, and no sign of lenders capitulating either.
Options positioning offers no contrarian read. The put/call ratio runs at 0.38, almost exactly in line with its 20-day average of 0.38 and sitting near its 52-week low of 0.36. That is the least defensive options structure possible on a stock that has just dropped 12% in a week — a notable absence of hedging demand, and a setup that fails to confirm the short sellers' conviction via the derivatives market.
The Street is similarly split. Goldman Sachs' Eric Sheridan raised his sell-rated target to $13 in May — still well below the current $16.61 price. That note is now just inside the 30-day window and represents the most recent meaningful analyst action on GRPN. The mean price target across the small analyst community runs at $26, but that figure is heavily influenced by bullish small-cap boutique targets of $44-$47 that date from mid-to-late 2025. The Goldman target — the only recent update — sits 22% below where the stock trades today. Factor scores reflect the same tension: the short score ranks in the bottom 4th percentile of the universe, the DTC rank in the 14th, and EV/EBIT in the 3rd — all deeply bearish readings. The ORTEX combined short score has held at 75.8 for the past two weeks, essentially unmoved. Sector score is neutral at the 50th percentile, offering no lift.
The institutional register adds one interesting wrinkle. Pale Fire Capital remains the dominant holder at 26.8% of shares, unchanged. CEO Dusan Senkypl received a stock award of 345,000 shares on May 1 and now personally holds just under 3% of the company — a position that has grown meaningfully in recent months. The COO and CFO also received awards on the same date, though both executives sold shares concurrently at $14.89. That pattern — awards paired with immediate sells — reads as tax-driven rather than a directional bet on the stock. Net insider activity over the past 90 days is a mildly positive 98,000 shares, but the cash-settlement component is marginal.
The next earnings print is scheduled for August 6. After Q1 results in May — where the stock jumped over 12% on the day and extended gains for five days — there will be renewed focus on whether management's guidance for billings declines of 2.5%-5% proves too conservative or too optimistic. For now, the setup is one where a record-crowded short base is trimming almost imperceptibly, the borrow market remains near-fully locked, and the stock has stabilised just above its recent lows — with the August print the next defined event that could force either side to move.
See the live data behind this article on ORTEX.
Open GRPN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
